Sanofi Consumer Healthcare India cash flow

Latest FY26
Cash from operations
₹277cr−36.8% on FY25
Capital spending
₹7.6cr−23.2% on FY25
Free cash flow
₹270cr−37.1% on FY25
Cash from financing
−₹222cr−₹116 cr in FY25
₹ crore except per share
Tap a line for its trendLast 12Mto Sep 2026FY26Dec 2025FY25Dec 2024
Adjustments to reconcile profit — non-cash items
—11.74.5
—0.02.9
—2.03.9
—−15.2−11.8
—−1.01.0
—−2.8−0.1
—0.00.1
Changes in working capital
—−21.055.7
—−14.017.9
—4.3201
—0.4−2.8
—−21.7−5.7
—−0.40.0
—9.310.3
—2.30.0
—−13.027.0
—1.012.8
Cash from operating activities
376320247
—−58.1317
—262563
—15.20.0
—0.0124
—277439
Cash from investing activities
—7.69.9
—0.011.8
—−7.61.9
Cash from financing activities
—7.80.0
——0.4
—0.0115
—1270.0
—87.40.0
—−222−116
—47.9325
—47.9325
——327
Reference items
370309271
37.8%35.2%37.4%
270270429
₹117.30₹117.30₹186.57
28.33×——
—1.16×2.43×
—0.0124
——115
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

SANOFICONR₹3,322.80

Sanofi Consumer Healthcare India Limited

· Pharma & Health
₹ CrorePeersPGHLSANOFISENORESINNOVACAPMOREPENLABIOLCPFDCASTRAZENMcap ₹7,642 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY25
31/12/2024
FY26
31/12/2025
Last 12M
30/09/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation4.511.7—
+ Impairment Loss / (Reversal)2.90.0—
+ Finance Costs3.92.0—
+ Interest Income-11.8-15.2—
+ Share-based Payments1.0-1.0—
+ Unrealised FX (Gain) / Loss-0.1-2.8—
+ Other Non-cash Items0.10.0—
Changes in Working Capital
+ Inventories55.7-21.0—
+ Trade Receivables — Current17.9-14.0—
+ Other Financial Assets — Current200.94.3—
+ Other Financial Assets — Non-current-2.80.4—
+ Other Current Assets-5.7-21.7—
+ Other Bank Balances0.0-0.4—
+ Trade Payables — Current10.39.3—
+ Other Financial Liabilities — Current0.02.3—
+ Other Current Liabilities27.0-13.0—
+ Provisions — Current12.81.0—
Cash from Operating Activities
Profit Before Tax (per I/S)246.8320.3375.8
+ Total Adjustments (incl. Working Capital)316.6-58.1—
Cash from Operations (pre-tax)563.4262.2—
+ Interest Received — Operating0.015.2—
+ Income Taxes Paid124.40.0—
Cash from Operating Activities439.0277.4—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)9.97.6—
+ Interest Received — Investing11.80.0—
Cash from Investing Activities1.9-7.6—
Cash from Financing Activities
+ Payment of Lease Liabilities0.07.8—
+ Payment of Finance Lease Liabilities0.4——
+ Interest Paid115.20.0—
+ Dividends Paid0.0126.7—
+ Income Taxes (Paid) / Refund — Financing0.087.4—
Cash from Financing Activities-115.6-221.9—
Net Changes in Cash (pre-FX)325.347.9—
Net Changes in Cash325.347.9—
Closing Cash326.9——
Reference Items
EBITDA270.6309.0369.6
EBITDA Margin %37.3535.1837.75
Free Cash Flow (CFO − Capex)429.1269.8269.8
Free Cash Flow per Basic Share186.57117.30117.30
Price to Free Cash Flow——28.33
Cash Flow to Net Income2.431.16—
Cash Paid for Taxes124.40.0—
Cash Paid for Interest115.2——
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.